About

Coalition for Epidemic Preparedness Innovations (CEPI)

Launched in 2017, CEPI is an international coalition of governments, academic, philanthropic, private, public, and intergovernmental institutions. Our mission is to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need.

 

A commitment to equitable access is inscribed in CEPI’s DNA. It is core to CEPI’s vision of a world in which epidemics and pandemics are no longer a threat to humanity. CEPI’s commitment to equitable access informs every aspect of our work and has done so since our very beginnings.

 

Equitable access to epidemic or pandemic vaccines in the context of an outbreak means that appropriate vaccines are first available to populations when and where they are needed to end an outbreak or curtail an epidemic or pandemic, regardless of ability to pay.

 

Equity is at the heart of CEPI’s 100 Days Mission: its central goal is to enable timely availability of CEPI-supported products to those at risk, starting in just 100 days. That’s because being able to start delivering effective vaccines within 100 days of a threat emerging – wherever it is in the world, to whoever needs it most – will systematically reduce the threat posed by future infectious disease outbreaks for everyone, everywhere.  

 

Of course, for the 100 Days Mission to achieve the greatest possible public health impact, the world needs a global health security system that is configured to deliver equitable outcomes. The COVID-19 pandemic has made it painfully clear that is not currently the case.

 

As we recover from the pandemic and prepare for new threats, it is vital that the system is re-engineered to produce better, more equitable outcomes in the future. CEPI is actively contributing, through its investments and its advocacy and policy engagements, to the urgently needed redesign of the system.

 

Role purpose

The Manufacturing and Supply Chain (MSC) Division’s primary goal is to ​support and drive vaccine process development, technical innovations, readiness for 100 Days Mission, and sustainable vaccine manufacturing for equitable epidemic and pandemic preparedness. The division is composed of 3 departments: CMC, MSC Innovations and Manufacturing and Supply Chain Networks, all supported by Executive Director’s office team. MSC Innovations is responsible for funding, leading and implementing technology projects in collaboration with R&D to achieve CEPI’s objectives of speed, scale and access.

 

The Director MSC Innovations, reporting to the ED Manufacturing and Supply Chain (MSC) Division, leads the department in driving innovative technology initiatives that support CEPI’s 100 DM and equitable access goals. This includes, directly and through a team of experts, developing and managing Calls for Proposals (CfP)’s in close collaboration with R&D and external stakeholders with a deep understanding of the current landscape of innovative technologies.

 

Major Duties and Responsibilities

  • Demonstratable leadership and management skills at all levels and within highly matrixed organizations.
  • Responsible for the MSC Innovations Department operating and investment budgets.
  • Responsible for execution of CEPI 2.0 strategy in the field of manufacturing innovations.
  • Able to operate and adapt successfully in a frequently changing environment and lead MSC Innovation activities, e.g. develop new CfP’s to enable CEPI’s strategy on 100 DM and Equitable access.
  • Act as PL in some Innovative tech projects. Ensure effectiveness and efficiency of project milestones and budget control – ensuring timely reviews for effective decision making and documentation transfers.
  • Outstanding technical written, verbal and interpersonal communication skills – Concrete communicator and motivational facilitator.
  • Strong interpersonal skills, able to work in different roles in various projects and cultural environments, to reach consensus and develop effective international collaboration.

 

Profile

Core Competencies – functional/technical/behavioural

  • Minimum 10 years of experience in the pharmaceutical industry and/or relevant government/non-profit organization, with proven track record in strategic planning, execution, and CMC development.
  • Able to work proactively as a self-motivated team player in a cross functional matrix organisation.
  • Experience in active and adaptive portfolio management to deliver strategic goals and objectives, including significant experience of managing partners to ensure effective and cost-efficient delivery.
  • Proven collaboration skills, including ability to manage shared project implementation and problem-solve.
  • Open and agile mindset, can quickly adapt and take advantage of new situations and requests.
  • Able to lead and motivate teams and project groups.
  • Strong interpersonal skills, able to work in different roles in various projects and cultural environments, to reach consensus and develop effective international collaboration.
  • Strong communication skills, able to represent CEPI at international events and ensure the necessary flow of information with the different stakeholders.

 

Educational and Experience Requirements

    • Advanced degree (MSc /PhD) in relevant field.
    • Broad understanding of end-to-end vaccine development from discovery to late-stage development and current challenges in vaccine development.
    • Experience working across cultures and countries (internationally) is preferred.
    • Experience with manufacturing targeting endemic regions of low to middle-income countries a plus.
    • Project lead, management and regulatory experience a plus.

 

Terms of Appointment

This is a full-time permanent position. Salary is competitive and commensurate with qualifications and experience. A benefits package is also included.  

 

Role Location

The role is based in London, UK, Oslo, Norway, or the United States.

 

Up to 30% travel.

 

How to Apply

To apply for this position, please ensure yoju complete the Application Form provided below by 16 December 2024 (23:59 hrs, GMT -5). It is essential that you submit your CV in English, specifically in Microsoft Word format (.doc/.docx), not exceeding 10MB.

 

Applications in other languages or formats will not be considered.

 

Rest assured, all information will be handled with the utmost confidentiality.

 

SRI Executive is exclusively retained by Coalition for Epidemic Preparedness Innovations (CEPI) to undertake this assignment.

 

Application form

Personal Details
Work Experience
Attach Resume (Please only upload documents in Word Document format, not exceeding 10MB)
Required Field
Any Additional Documentation (Optional)
Loading...